GGrantIndex
Sort

261,768 grants matching gene therapy

Targeting the PD - 1 pathway to eradicate SIV/HIV

$1,790,318
Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2015 · AI

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$1,790,298
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Vascular remodeling in patients with rare genetic disorders

$1,790,284
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Moffitt Skin Cancer SPORE

$1,789,062
Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA

GENE THERAPY FOR CYSTIC FIBROSIS

$1,789,000
Weill Medical College Of Cornell Univ · P01 · FY2000 · HL

HSPH-NIEHS Center for Environmental Health

$1,788,803
Douglas W Dockery · Harvard School Of Public Health · P30 · FY2012 · ES

1/2 Genetics at an extreme: an efficient genomic study of individuals with clinically severe major depression receiving ECT

$1,788,642
Peter P Zandi · Johns Hopkins University · R01 · FY2019 · MH

Mechanism-Based Targeting of Mantle Cell Lymphoma

$1,788,373
Selina Y Chen-Kiang · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · CA

Batten Disease Clinical Research Consortium

$1,788,368
Erika Augustine · Hugo W. Moser Res Inst Kennedy Krieger · U54 · FY2025 · HD

Gene therapy for Alzheimer's disease using virally delivered Aβ variants

$1,788,342
Joanna L Jankowsky · Baylor College Of Medicine · RF1 · FY2021 · AG

CENTER FOR AIDS RESEARCH(CFAR)

$1,788,256
Jonathan Karn · Case Western Reserve University · P30 · FY2008 · AI

Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity

$1,787,959
Deborah A. Meyers · Wake Forest University Health Sciences · RC2 · FY2010 · HL

Roswell Park Ovarian Cancer SPORE

$1,787,915
Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2025 · CA

Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr

$1,787,395
Roberta Anderson Ballard · University Of California, San Francisco · U01 · FY2009 · HL

GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS

$1,787,287
Johns Hopkins University · P01 · FY2003 · HL

Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS

$1,786,891
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency

$1,786,840
David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · DK

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$1,786,679
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2009 · CA

IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

$1,786,679
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

The role of post-natal skeletal stem cells in health and disease

$1,786,647
Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE

PPG-GENE THERAPY FOR CYSTIC FIBROSIS LUNG DISEASE

$1,786,606
University Of Iowa · P01 · FY2005 · HL

Project 3

$1,786,272
Michael C. Milone · University Of Pennsylvania · U54 · FY2019 · CA

Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort

$1,786,162
Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2017 · AI

Childhood Cancer Gene Program Project Grant

$1,785,841
St. Jude Children'S Research Hospital · P01 · FY2002 · CA

Retrovirus Models of Cancer

$1,785,690
Patrick Lee Green · Ohio State University · P01 · FY2015 · CA